S&P 500   4,283.85 (+0.24%)
DOW   33,573.28 (+0.03%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
S&P 500   4,283.85 (+0.24%)
DOW   33,573.28 (+0.03%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
S&P 500   4,283.85 (+0.24%)
DOW   33,573.28 (+0.03%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
S&P 500   4,283.85 (+0.24%)
DOW   33,573.28 (+0.03%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
NASDAQ:IBB

iShares Biotechnology ETF (IBB) Price, Holdings, & News

$129.08
-0.39 (-0.30%)
(As of 06/6/2023 ET)
Compare
Today's Range
$128.92
▼
$129.87
50-Day Range
$126.17
▼
$131.92
52-Week Range
$104.29
▼
$138.74
Volume
937,505 shs
Average Volume
1.53 million shs
Market Capitalization
$7.68 billion
Assets Under Management
$7.57 billion
Dividend Yield
0.28%
Net Expense Ratio
0.44%
ProfileChartDividendInstitutional OwnershipHeadlinesHoldingsOptions ChainSEC FilingsShort InterestSocial Media
IBB stock logo

About iShares Biotechnology ETF (NASDAQ:IBB)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

Receive IBB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

IBB ETF News Headlines

May 31, 2023 | marketbeat.com
The How and Why of Investing in Biotech Stocks (IBB)
One fascinating sector to invest in is the biotech sector which includes companies involved in the research and development of therapeutics and vaccines
May 31, 2023 | americanbankingnews.com
iShares Biotechnology ETF (NASDAQ:IBB) Sees Significant Decline in Short Interest
June 6, 2023 | Behind the Markets (Ad)
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software"
Denver firm proves its possible to use AI to save the lives of soldiers in combat. England, Germany, Japan and Australia have all signed contracts within the past 18 months. Get the name of the stock here >>>
May 31, 2023 | msn.com
Unusual Put Option Trade in BlackRock Institutional Trust Company N.A. - iShares Biotechnology ETF (IBB) Worth $94.70K
May 11, 2023 | forbes.com
Best Biotech Stocks
May 10, 2023 | finance.yahoo.com
Biotech ETFs Pop on M&A Resurgence
April 24, 2023 | msn.com
3 Pharma Stocks That Could See a Surge in Demand in 2023
April 14, 2023 | americanbankingnews.com
Investors Buy High Volume of iShares Biotechnology ETF Call Options (NASDAQ:IBB)
June 6, 2023 | Behind the Markets (Ad)
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software"
Denver firm proves its possible to use AI to save the lives of soldiers in combat. England, Germany, Japan and Australia have all signed contracts within the past 18 months. Get the name of the stock here >>>
April 7, 2023 | marketwatch.com
Trend Tracker for Ishares Biotechnology Etf $IBB
See More Headlines

IBB Price History

Fund Details

Issuer
iShares
Fund Name
iShares Biotechnology ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:IBB
Inception Date
2/5/2001
Fund Manager
Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
ICE Biotechnology Index (TR) (USD)
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
275

Fund Statistics

Assets Under Management
$7.57 billion
Average Daily Volume
$1.49 million
Discount/Premium
7.57%

Administrator, Advisor and Custodian

Administrator
JPMorgan Chase Bank, N.A.
Advisor
BlackRock Fund Advisors
Custodian
JPMorgan Chase Bank, N.A.
Distributor
BlackRock Investments, LLC
Transfer Agent
JPMorgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Latour Trading

Options

Optionable
Optionable
Options Volume
1,805
Put Options
1,336
Call Options
469
Short Interest
9,370,000 shs

Miscellaneous

Outstanding Shares
59,500,000
Beta
0.83
Creation Unit
50,000
Creation Fee
$614.00


iShares Biotechnology ETF Expenses

TypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.44%0.54%0.52%0.45%0.49%
Other Expenses0.00%0.41%0.48%0.28%0.51%
Total Expense0.44%0.69%0.67%0.54%0.66%
Fee Waiver0.00%-0.39%-0.49%-0.21%-0.52%
Net Expense0.44%0.60%0.58%0.50%0.55%

iShares Biotechnology ETF (IBB) Holdings & Exposure

Top 10 IBB Holdings

IBB Sector Exposure

IBB Industry Exposure

Full Holdings Details

Key Executives

  • George G. C. Parker Ph.D.
    Independent Chairman of the Board of Trustees
  • Michael Arthur Latham
    President, Trustee
  • Jack Gee
    Chief Financial Officer, Treasurer
  • Geoffrey D. Flynn
    Chief Operating Officer, Executive Vice President

  • Bio & Compensation - 
  • Amy Schioldager
    Executive Vice President
  • Ira P. Shapiro
    Vice President, Chief Legal Officer
  • Matt Tucker
    Vice President

  • Bio & Compensation - 
  • Eilleen M. Clavere
    Secretary
  • Cecilia H. Herbert
    Independent Trustee
  • Charles A. Hurty
    Independent Trustee

Similar ETFs

Institutional Ownership

View All Institutional Transactions













IBB ETF - Frequently Asked Questions

How have IBB shares performed in 2023?

iShares Biotechnology ETF's stock was trading at $131.29 at the start of the year. Since then, IBB stock has decreased by 1.4% and is now trading at $129.47.
View the best growth stocks for 2023 here.

Are investors shorting iShares Biotechnology ETF?

iShares Biotechnology ETF saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 9,370,000 shares, a decline of 6.4% from the April 30th total of 10,010,000 shares. Based on an average trading volume of 1,574,100 shares, the short-interest ratio is currently 6.0 days.
View iShares Biotechnology ETF's Short Interest.

How often does iShares Biotechnology ETF pay dividends? What is the dividend yield for iShares Biotechnology ETF?

iShares Biotechnology ETF announced a quarterly dividend on Monday, December 12th. Shareholders of record on Wednesday, December 14th will be given a dividend of $0.101 per share on Monday, December 19th. This represents a $0.40 annualized dividend and a dividend yield of 0.31%. The ex-dividend date is Tuesday, December 13th. This is an increase from the stock's previous quarterly dividend of $0.03.
Read our dividend analysis for IBB.

What does IBB invest in?

iShares Biotechnology ETF is a equity fund issued by iShares. IBB focuses on health care investments and follows the ICE Biotechnology Index (TR) (USD). The fund's investments total to approximately $7.57 billion assets under management.

What stocks does iShares Biotechnology ETF hold?

IBB invests in 275 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Amgen (AMGN), Gilead Sciences (GILD), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Vertex Pharmaceuticals (VRTX), Moderna (MRNA) and Moderna (MRNA).

What is the management fee for iShares Biotechnology ETF?

iShares Biotechnology ETF's management fee is 0.44% and has no other recorded expenses or fee waivers. The net expense ratio for IBB is 0.44%.

When did iShares Biotechnology ETF's stock split?

iShares Biotechnology ETF's stock split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly created shares were issued to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

What other stocks do shareholders of iShares Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL).

What is iShares Biotechnology ETF's stock symbol?

iShares Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

Who are iShares Biotechnology ETF's major shareholders?

iShares Biotechnology ETF's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Citigroup Inc. (3.32%), JPMorgan Chase & Co. (3.26%), Healthcare of Ontario Pension Plan Trust Fund (1.63%), Commerce Bank (1.21%), Proficio Capital Partners LLC (1.10%) and LPL Financial LLC (1.04%).

How do I buy shares of iShares Biotechnology ETF?

Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares Biotechnology ETF's stock price today?

One share of IBB stock can currently be purchased for approximately $129.47.

How much money does iShares Biotechnology ETF make?

iShares Biotechnology ETF (NASDAQ:IBB) has a market capitalization of $7.70 billion.

This page (NASDAQ:IBB) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -